$DC
Dakota Gold Corp.

2024 Q1 Form 10-K Financial Statement

#000106299324007319 Filed on March 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.248M $2.459M $9.691M
YoY Change -17.88% 10.53% -59.52%
% of Gross Profit
Research & Development $6.546M $6.964M $28.35M
YoY Change -4.27% 31.39% 286.47%
% of Gross Profit
Depreciation & Amortization $67.61K $64.73K $302.1K
YoY Change 11.3% 12.05% 125.42%
% of Gross Profit
Operating Expenses $8.794M $9.423M $38.04M
YoY Change -8.16% 25.22% 21.61%
Operating Profit -$8.794M -$38.04M
YoY Change -8.16% 21.61%
Interest Expense $37.44K $236.1K $369.9K
YoY Change 8.08% 276.15% 932.26%
% of Operating Profit
Other Income/Expense, Net $182.6K $369.9K
YoY Change 427.17% -517.0%
Pretax Income -$8.611M -$9.187M -$37.67M
YoY Change -9.74% 23.11% 20.09%
Income Tax -$16.39K -$368.9K -$1.217M
% Of Pretax Income
Net Earnings -$8.595M -$8.818M -$36.45M
YoY Change -7.25% 27.85% 188.97%
Net Earnings / Revenue
Basic Earnings Per Share -$0.10 -$0.47
Diluted Earnings Per Share -$0.10 -$0.10 -$0.47
COMMON SHARES
Basic Shares Outstanding 87.70M shares 86.74M shares 78.25M shares
Diluted Shares Outstanding 87.40M shares 78.25M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.11M $25.55M $25.55M
YoY Change -25.48% 6.84% -38.29%
Cash & Equivalents $15.11M $25.55M $25.55M
Short-Term Investments
Other Short-Term Assets $971.3K $676.0K $676.0K
YoY Change 13.91% 9.23% 79.46%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $16.08M $26.22M $26.22M
YoY Change -24.3% 6.44% -37.37%
LONG-TERM ASSETS
Property, Plant & Equipment $2.281M $2.262M $81.61M
YoY Change 82.41% 78.56% 4.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $445.5K $371.9K $371.9K
YoY Change 27.86% -2.31% 1759.3%
Total Long-Term Assets $84.97M $81.98M $81.98M
YoY Change 5.74% 1.98% 4.82%
TOTAL ASSETS
Total Short-Term Assets $16.08M $26.22M $26.22M
Total Long-Term Assets $84.97M $81.98M $81.98M
Total Assets $101.0M $108.2M $108.2M
YoY Change -0.54% 3.03% -9.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.386M $2.705M $2.705M
YoY Change -28.19% 54.39% 31.87%
Accrued Expenses $327.2K $1.327M $1.462M
YoY Change -38.74% 108.99% 212.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.859M $4.486M $4.486M
YoY Change 55.43% 78.39% 76.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $60.74K $94.52K $94.52K
YoY Change
Total Long-Term Liabilities $60.74K $94.52K $94.52K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.859M $4.486M $4.486M
Total Long-Term Liabilities $60.74K $94.52K $94.52K
Total Liabilities $3.983M $4.666M $4.666M
YoY Change 12.52% 21.29% -25.34%
SHAREHOLDERS EQUITY
Retained Earnings -$51.26M -$42.66M
YoY Change 231.1% 586.42%
Common Stock $87.70K $86.74K
YoY Change 16.48% 18.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $97.06M $103.5M $103.5M
YoY Change
Total Liabilities & Shareholders Equity $101.0M $108.2M $108.2M
YoY Change -0.54% 3.03% -9.89%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$8.595M -$8.818M -$36.45M
YoY Change -7.25% 27.85% 188.97%
Depreciation, Depletion And Amortization $67.61K $64.73K $302.1K
YoY Change 11.3% 12.05% 125.42%
Cash From Operating Activities -$10.17M -$5.993M -$31.20M
YoY Change 20.23% -1.45% 214.71%
INVESTING ACTIVITIES
Capital Expenditures $122.9K $537.3K $1.054M
YoY Change 175.25% 92.19% 114.17%
Acquisitions
YoY Change
Other Investing Activities -$20.74K -$2.820K -$98.57K
YoY Change 180.65% 392.85%
Cash From Investing Activities -$174.4K -$540.1K -$1.760M
YoY Change 142.11% 93.2% -80.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$92.50K 19.33M $34.59M
YoY Change -101.89% 777.14% -29.45%
NET CHANGE
Cash From Operating Activities -$10.17M -5.993M -$31.20M
Cash From Investing Activities -$174.4K -540.1K -$1.760M
Cash From Financing Activities -$92.50K 19.33M $34.59M
Net Change In Cash -$10.44M 12.79M $1.637M
YoY Change 186.94% -407.76% -94.54%
FREE CASH FLOW
Cash From Operating Activities -$10.17M -$5.993M -$31.20M
Capital Expenditures $122.9K $537.3K $1.054M
Free Cash Flow -$10.30M -$6.530M -$32.25M
YoY Change 21.04% 2.67% 209.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Security12g Title
Security12gTitle
Common stock, par value $0.001 per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
230894927 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2261979 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1266790 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4486242 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2514863 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2380905 usd
us-gaap Stock Issued1
StockIssued1
675000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
113834405 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
79344304 usd
CY2022Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
78737287 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7909971 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4516175 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
4910 usd
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
20911 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-25887 usd
us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
209213 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6741327 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1704445 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-27708 usd
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
256450 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
459375 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9270826 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10256221 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3514894 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
927573 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5755932 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
-5942 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
25460 usd
CY2022Q4 dc Deferred Tax Liabilities Mineral Properties
DeferredTaxLiabilitiesMineralProperties
7079154 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1012905 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7088050 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.86
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4201910 shares
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
72545 usd
dc Deferred Atm Offering Costs Offset Against Additional Paid In Capital
DeferredAtmOfferingCostsOffsetAgainstAdditionalPaidInCapital
78088 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
103536451 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
62500 shares
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1326986 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
634953 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
318843 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7503 usd
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.34
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
68750 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3287357 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.07
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y6M10D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
459375 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1217329 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2325156 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8287041 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7123439 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2896753 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2147387 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11183794 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-16564 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
85332 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1332118 usd
CY2023 dei Trading Symbol
TradingSymbol
DC
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q4 dc Deferred Tax Liabilities Mineral Properties
DeferredTaxLiabilitiesMineralProperties
1043466 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-24619 usd
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
SD
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
Denver, Colorado, USA
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
135097 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
94515 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023 us-gaap Exploration Costs
ExplorationCosts
28345452 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9690940 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-38036392 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-44304 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
414168 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
369864 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37666528 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
29457 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
55749 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1246786 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-36449199 usd
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78251025 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78251025 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72090163 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72090163 shares
CY2023 us-gaap Profit Loss
ProfitLoss
-36449199 usd
CY2023 us-gaap Depreciation
Depreciation
302078 usd
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
4322995 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1246786 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-50249 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1822947 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31197716 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1054320 usd
CY2023 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
607017 usd
CY2023 us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
98574 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1759911 usd
CY2023 dc Proceeds From Sale Of Common Stock On At Market Program
ProceedsFromSaleOfCommonStockOnAtMarketProgram
17946505 usd
CY2023 dc Proceeds From Orion Equity Investment
ProceedsFromOrionEquityInvestment
16820227 usd
dc Proceeds From Orion Equity Investment
ProceedsFromOrionEquityInvestment
0 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
72000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
18757 usd
CY2023 dc Withholding Of Employee Tax Payments On Restricted Stock Units
WithholdingOfEmployeeTaxPaymentsOnRestrictedStockUnits
263211 usd
dc Withholding Of Employee Tax Payments On Restricted Stock Units
WithholdingOfEmployeeTaxPaymentsOnRestrictedStockUnits
558005 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34594278 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1636651 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23911722 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25548373 usd
CY2023 us-gaap Stock Issued1
StockIssued1
0 usd
CY2023 dc Deferred Atm Offering Costs Offset Against Additional Paid In Capital
DeferredAtmOfferingCostsOffsetAgainstAdditionalPaidInCapital
176250 usd
CY2023 dc Accrual Of Atm Issuance Costs
AccrualOfAtmIssuanceCosts
0 usd
dc Accrual Of Atm Issuance Costs
AccrualOfAtmIssuanceCosts
100000 usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
675000 usd
dc Withholding Of Employee Tax Payment On Rsu
WithholdingOfEmployeeTaxPaymentOnRsu
558005 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101175738 usd
CY2023 dc Stock Issued During Period Value Common Stock Issued For Amortized Issuance Costs
StockIssuedDuringPeriodValueCommonStockIssuedForAmortizedIssuanceCosts
16820227 usd
CY2023 dc Stock Issued During Period Value Common Stock Issued For Orion Equity Investment Net Of Issuance Costs
StockIssuedDuringPeriodValueCommonStockIssuedForOrionEquityInvestmentNetOfIssuanceCosts
17839144 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
72000 usd
CY2023 dc Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
18757 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4322995 usd
CY2023 dc Stock Issued During Period Value For Payment Of Income Taxes Remitted On Rsus And Psus
StockIssuedDuringPeriodValueForPaymentOfIncomeTaxesRemittedOnRsusAndPsus
-263211 usd
CY2023 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-36449199 usd
CY2023 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On March 31, 2022, the Company completed a merger with Dakota Territory Resource Corp., a Nevada corporation ("Dakota Territory" or "DTRC"), pursuant to which Dakota Territory stockholders, other than Dakota Gold, were entitled to receive one share of Dakota Gold common stock for each share of Dakota Territory common stock (the "DTRC Merger").
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align: justify; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Use of Estimates</span></span></span></p> <p style="text-align: justify; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of the Company's financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates include valuation of stock-based compensation. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company's estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</span></span></p> </div>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align: justify; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Concentration of Credit Risk</span></span></span></p> <p style="text-align: justify; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents. The Company holds its cash in US and Canadian banks and United States treasury bills with a Canadian financial institution and the risk of default is considered to be remote. As part of its cash management process, the Company regularly monitors the relative credit standing of this institution.</span></span></p> </div>
CY2023 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
136000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1166 pure
CY2022 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
111000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
287000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3514894 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6741327 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10256221 usd
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1810449 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1704445 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3514894 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
39300000 usd
CY2023Q4 dc Operating Loss Carryforwards Gross Amount
OperatingLossCarryforwardsGrossAmount
8500000 usd
CY2022Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On March 8, 2022, the Company completed a reverse split of its common stock on a 1 for 35,641,667 / 49,398,602 basis.
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
72000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
18757 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
44586 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2023 dc Share Based Payment Exploration Expenses
ShareBasedPaymentExplorationExpenses
726159 usd
dc Share Based Payment Exploration Expenses
ShareBasedPaymentExplorationExpenses
713307 usd
CY2023 dc Share Based Payment General And Administrative
ShareBasedPaymentGeneralAndAdministrative
3596836 usd
dc Share Based Payment General And Administrative
ShareBasedPaymentGeneralAndAdministrative
2751093 usd
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
4322995 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3464400 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3349375 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
871447 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
183750 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.76
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.32
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3999572 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.89
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
333588 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.81
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.05
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4201910 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y9M29D

Files In Submission

Name View Source Status
0001062993-24-007319-index-headers.html Edgar Link pending
0001062993-24-007319-index.html Edgar Link pending
0001062993-24-007319.txt Edgar Link pending
0001062993-24-007319-xbrl.zip Edgar Link pending
dc-20231231.xsd Edgar Link pending
exhibit19-1.htm Edgar Link pending
exhibit23-1.htm Edgar Link pending
exhibit23-2.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
exhibit97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kxz001.jpg Edgar Link pending
form10kxz002.jpg Edgar Link pending
form10kxz003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
dc-20231231_def.xml Edgar Link unprocessable
dc-20231231_lab.xml Edgar Link unprocessable
dc-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10k_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dc-20231231_cal.xml Edgar Link unprocessable